- Home
- ICCC vs GTIM Comparison
ICCC vs GTIM Comparison
Compare ICCC & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- GTIM
- Stock Information
- Founded
- ICCC 1982
- GTIM 1987
- Country
- ICCC United States
- GTIM United States
- Employees
- ICCC N/A
- GTIM N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- ICCC Health Care
- GTIM Consumer Discretionary
- Exchange
- ICCC Nasdaq
- GTIM Nasdaq
- Market Cap
- ICCC 60.1M
- GTIM 17.1M
- IPO Year
- ICCC 1987
- GTIM 1990
- Fundamental
- Price
- ICCC $6.71
- GTIM $1.78
- Analyst Decision
- ICCC
- GTIM
- Analyst Count
- ICCC 0
- GTIM 0
- Target Price
- ICCC N/A
- GTIM N/A
- AVG Volume (30 Days)
- ICCC 41.8K
- GTIM 9.7K
- Earning Date
- ICCC 08-12-2025
- GTIM 07-31-2025
- Dividend Yield
- ICCC N/A
- GTIM N/A
- EPS Growth
- ICCC N/A
- GTIM 65.30
- EPS
- ICCC N/A
- GTIM 0.09
- Revenue
- ICCC $27,302,766.00
- GTIM $144,322,000.00
- Revenue This Year
- ICCC N/A
- GTIM N/A
- Revenue Next Year
- ICCC N/A
- GTIM N/A
- P/E Ratio
- ICCC N/A
- GTIM $18.83
- Revenue Growth
- ICCC 28.29
- GTIM 4.14
- 52 Week Low
- ICCC $3.34
- GTIM $1.51
- 52 Week High
- ICCC $7.60
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- ICCC 49.68
- GTIM 53.83
- Support Level
- ICCC $5.63
- GTIM $1.63
- Resistance Level
- ICCC $7.14
- GTIM $1.82
- Average True Range (ATR)
- ICCC 0.64
- GTIM 0.09
- MACD
- ICCC -0.06
- GTIM 0.01
- Stochastic Oscillator
- ICCC 42.58
- GTIM 60.00
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.